- Gemcitabine (CAS 95058-81-4) is a high-purity antitumor API, a potent pyrimidine antimetabolite designed for targeted cancer therapy. With a precise molecular structure, it interferes with tumor cell DNA synthesis and replication, effectively inhibiting the proliferation of malignant cells and inducing apoptosis.
- Produced under strict GMP standards, this API ensures consistent purity (≥99%), potency, and stability, making it ideal for pharmaceutical formulation. It is widely applied in the development of drugs for pancreatic cancer, non-small cell lung cancer, bladder cancer, and breast cancer treatment, catering to the needs of pharmaceutical manufacturers and research institutions focusing on antitumor pharmaceutical R&D.
- Its unique antimetabolite mechanism minimizes damage to normal cells while maximizing tumor-inhibiting efficacy, balancing therapeutic effect with safety. As a key raw material in clinical chemotherapy, Gemcitabine delivers reliable performance for both preclinical research and large-scale pharmaceutical production, supporting the development of effective antitumor treatments.
Gemcitabine (CAS 95058-81-4) – Antitumor API
$1,000.00
Gemcitabine is a chemotherapy drug (antimetabolite) used to treat various solid tumors, including pancreatic, non-small cell lung, bladder, ovarian, and metastatic breast cancers.
Be the first to review “Gemcitabine (CAS 95058-81-4) – Antitumor API”
Reviews
There are no reviews yet.